Prasad covers the Healthcare sector, focusing on stocks such as Teva Pharmaceutical ... data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today ...

Austedo, Teva's treatment for tardive dyskinesia and chorea associated with Huntington's disease, has been a standout performer with projected year-over-year growth of 20%. The generic drug ...

Austedo, Teva's treatment for tardive dyskinesia and chorea associated with Huntington's disease, has been a standout performer with projected year-over-year growth of 20%. The generic drug segment, ...

Prasad covers the Healthcare sector, focusing on stocks such as Teva Pharmaceutical, Elanco Animal Health, and Jazz Pharmaceuticals ... to this exclusive data and discover crucial insights to guide ...

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

Analysts are bullish on Teva, which is once again Israel's most valuable company, due to an improved US generics price environment and promising branded drug pipeline. Most pf the investment bank ...

Teva's long haul to a turnaround ... acetate), and saddled with debt from its takeover of generics business Actavis. Since then, newer new drugs Austedo (deutetrabenazine) for Huntington's disease ...

IJNSB assures heart patients covered by govt that branded drugs not the only option PETALING JAYA: Generic drugs prescribed for heart patients covered by the government are as safe and effective ...